Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. (Q43654472)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. |
scientific article |
Statements
1 reference
Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. (English)
1 reference
1 reference
Niederberger E
1 reference
Vetter G
1 reference
Schmidtko A
1 reference
Schmidt H
1 reference
Euchenhofer C
1 reference
Bräutigam L
1 reference
Grösch S
1 reference
Geisslinger G
1 reference
1 July 2001
1 reference
1 reference